Skip to main content
US EQUITIES PRE-MARKET CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
ME

MEDPStock

Nasdaq Global Select Market · Healthcare · US

$633.98 last close 2026-11-19
Open in terminalCompare
Price alert

Verdicts genuinely change. Free email alert the moment MEDP's does — no target price to set, unlike a price alert.

Stable Ratio screen, 4 of 6 decided standards passing. No standard's deciding ratio sits within 3 points of its line. What would change it

Sharia status
COMPLIANT
Per our in-house ratio engine
4 of 6 pass our financial screen — the standards disagree — 1 of 7 could not be computed
🕌 Held by MNZL Purification 0.00% *HTR non-permissible income <0.01%
🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
🟠 NOT YET
The main driver: insider selling on the open market. More negatives than positives right now. The setup isn't ready...
Scores: 1 bullish / 2 bearish
32
of 100
Setup confidence — system conviction, not win probabilityF

Trade plan

Posted with a stop, a target and the level that invalidates it. It resolves into the public record either way.

CANDLE · SCALP
Entry
$602.52
Stop
$594.37
Target
$618.82
Risk : Reward 2.0R

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure0 of 5 timeframes bullish · 56.5% aligned
VWAPPrice below VWAP ($647.92)
VolumeRelative volume 2.7× the 20-day average
Momentum10-day rate of change -0.2%
Overall readNOT YET

MEDP is currently considered halal (Sharia-compliant), per our in-house ratio engine. See the full ratio breakdown and business-activity screen below for the reasoning.

This sits among 434 compliant Healthcare stocks we track. See compliant Healthcare stocks →

Market & analysts
Price target
$651.31
+2.7% · 13 analysts
Institutional own.
85.7%
of shares
Momentum (10d)
-0.2%
rate of change
SMC grade
F · 32
56.5% aligned
🕌 MNZL
Held by real halal ETF(s)
0.00% *
Purification ratio (secondary provider, uncertain)
<0.01%
Non-permissible income — HTR, from filings (2026-09-30)
F · 32
SMC grade — 56.5% timeframe alignment
-0.2%
Rate of change (10d)
$651.31
Price target (+2.7%) · 13 analysts
85.7%
Institutional ownership

How the status reached this point

Compliant · status tracked since Nov 17, 2026

No change to MEDP’s published status has been recorded since our daily status check began on Nov 17, 2026. What it read before then is not on record here.

Read once a day from our own screen, last on Nov 19, 2026. The per-methodology record is under “What changed, and when” in the in-house research.

Free email, sent when our compliance re-scan finds a change.

🕌 In-house Compliance Research

Computed from published company financials, balance sheet as of 2026-09-30. These ratios come from the issuer's own published statements rather than structured SEC data.

AAOIFI divides by the market cap: $18.3B as of 2026-11-18. At the 2026-11-19 close it is about $17.7B (the stored market cap moved by the share price since, not a new share count), and at that cap AAOIFI's interest-bearing investments ratio would read 4.0% (3.9% at the stored cap, against a 30% line). The published verdict changes only when the company is re-screened.

Business activity: cleared (no excluded categories detected)

AAOIFI Pass 3 of 3 ratios pass
RatioValueThresholdResult
Interest-bearing debt (bound) at most 9.40% 30.00% Pass
Interest-bearing investments 3.86% 30.00% Pass(26.1pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
Usmani Unverified⚠️ a figure this standard needs was not available, so it could not be scored — the rows below show what was and was not computed 4 of 5 computed, all pass
RatioValueThresholdResult
Interest-bearing debt
debt not reported
not available 33.00% Unverified
Interest-bearing investments 30.63% 33.00% Pass(2.4pp buffer)
Non-liquid assets 49.93% at least 20.00% Pass(29.9pp above the floor)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
Net liquid assets per share $-343.1M under mkt cap $18.3B Pass
MSCI Fail 3 of 4 computed, 2 pass, 1 fails
RatioValueThresholdResult
Interest-bearing debt
debt not reported
not available 33.33% Unverified
Cash + interest-bearing securities 30.63% 33.33% Pass(2.7pp buffer)
Accounts receivable 50.07% 33.33% Fail(16.7pp over)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
FTSE Fail 3 of 4 computed, 2 pass, 1 fails
RatioValueThresholdResult
Interest-bearing debt
debt not reported
not available 33.33% Unverified
Cash + interest-bearing securities 30.63% 33.33% Pass(2.7pp buffer)
Accounts receivable 50.07% 50.00% Fail(0.1pp over)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
Dow Jones Islamic Market Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt (bound) at most 12.36% 33.00% Pass
Cash + interest-bearing securities 5.08% 33.00% Pass(27.9pp buffer)
Accounts receivable 3.22% 33.00% Pass(29.8pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
S&P Shariah Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt (bound) at most 13.19% 33.00% Pass
Cash + interest-bearing securities 5.42% 49.00% Pass(43.6pp buffer)
Accounts receivable 3.44% 49.00% Pass(45.6pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
MSCI M-Series Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt (bound) at most 13.19% 33.33% Pass
Cash + interest-bearing securities 5.42% 33.33% Pass(27.9pp buffer)
Accounts receivable 8.86% 49.00% Pass(40.1pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

How close is it to flipping?

Every current reading against its own line, closest first. A verdict is only as durable as that distance.

MSCI Islamic Index (% of total assets)cash and interest ratio 2.7pts
FTSE Shariah Global Equity Index Series (% of total assets)cash and interest ratio 2.7pts
AAOIFI Standard 21 (% of market cap)non permissible income ratio 5.0pts
MSCI Islamic Index (% of total assets)receivables ratio 16.7pts
FTSE Shariah Global Equity Index Series (% of total assets)receivables ratio 0.1pts

The numbers the ratios are built from

Read from MEDP's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.

LineFigureAs reportedRead from
RevenueTotal revenue for the period $2.5B 2026-09-30 RevenueFromContractWithCustomerExcludingAssessedTax
Interest-bearing debtBorrowings — which definition was stored is not recorded not measured — —
Cash and interest-bearing securitiesCash, equivalents and marketable securities $705.3M 2026-09-30 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
Total assetsBalance sheet total $2.3B 2026-09-30 Assets
Market capDenominator for AAOIFI $18.3B live quote price x shares
36-month average market capDenominator for S&P Shariah and MSCI M-Series $12.5B 756 trading days closes x shares
24-month average market capDenominator for Dow Jones Islamic Market $13.3B 504 trading days closes x shares
Non-permissible revenueInterest and excluded income $0 2026-09-30 no interest-income tag reported in 3+ years (treated as $0)

Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.

Sources

Filing information. Balance sheet: Quarterly report (10-Q) filed 2026-10-22, period ended 2026-09-30. Income statement: Annual report (10-K) filed 2026-02-10, period ended 2026-09-30. Screened 2026-11-18.

  • Total assets$2.3B
    Assets · period ended 2026-09-30 · 10-Q filed 2026-10-22
  • Cash and interest-bearing securities$705.3M
    CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · period ended 2026-09-30 · 10-Q filed 2026-10-22
  • Receivables$447.6M
    ReceivablesNetCurrent · period ended 2026-09-30 · 10-Q filed 2026-10-22
  • Revenue$2.5B
    RevenueFromContractWithCustomerExcludingAssessedTax · period ended 2025-12-31 · 10-K filed 2026-02-10
  • Interest income (non-permissible)$0
    no interest-income tag reported in 3+ years (treated as $0) · income statement as of 2026-09-30 · no filing link for this figure
  • Market cap$18.3B
    Market quote passed in by the screen (Finnhub company profile; Yahoo Finance where Finnhub has none), 2026-11-18 · not a filing figure, so no link

4 reported values cited from 2 SEC filings, read from SEC's XBRL company facts when this symbol was screened. A link opens the filing's index on EDGAR.

What changed, and when

Verdict history for MEDP. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.

  • 2026-11-18 Unverified → Fail filing re-screen

Tracked since 2026-09-07.

Revenue by business segment

How MEDP’s $2.5B of revenue for the fiscal year 2025-01-01 to 2025-12-31 splits across what it sells, as the company tags it in its own 10-K.

Fiscal year ended 2025-12-31
SegmentShareRevenue
Oncology 29.5% $747.6M
Other 29.4% $745.0M
Metabolic 16.2% $408.5M
AVAI 10.1% $254.8M
Central Nervous System 9.5% $239.4M
Cardiology 5.3% $134.9M

These are the company’s own segment names and figures. They do not say whether a line of business is permissible; our business-activity screen does.

Source: 10-K filed 2026-02-10 (accession 0001668397-26-000006), read from its XBRL on SEC EDGAR. Shares are of total revenue; subtotals and overlapping cuts the filing also tags are left out, so the lines add up to the total.

What would change the status

The headline verdict is the majority of the decided ratio standards — 4 pass and 2 fail of 7 — with a business-activity screen and any hold applied on top. Balance sheet as of 2026-09-30; market cap as stored on 2026-11-18.

No standard's deciding ratio sits within 3 points of its line.

The ratios that move with the share price

AAOIFI's investments ratio (3.9% against a 30% line) would only fail if the market cap fell by 87%, to $2.4B. At the 2026-11-19 close it would read 4.0%.

Only AAOIFI divides by the market cap itself. The Dow Jones, S&P and MSCI M-Series standards divide by a 24- or 36-month average and the others by total assets, so a day's price move does not reach them. Figures are the screen's own; the live market cap differs from the stored one.

Shariah-compliant alternatives

Compliant companies in Diagnostics & Research listed on the same market, largest first. Each is screened on its own; none carries a documented concern or a hold.

CompanyMarket capPrice, day
DHRDanaher Corp. $146.0B —
NTRANatera Inc $47.2B $289.92+0.15%
IDXXIdexx Laboratories, Inc. $44.1B —
AAgilent Technologies Inc. $43.3B —
WATWaters Corp. $37.3B —

A dash means no fresh quote is cached for that symbol; this list does not fetch one.

Funds that hold MEDP

18 of the 279 funds whose filed holdings we currently hold own MEDP shares. That set is a fixed list of widely held index funds and Shariah funds, plus the funds our look-through has read most recently. It is not every fund that owns MEDP.

Shariah funds
FundMEDP in fundFund compliant by weight
MNZL Manzil Russell Halal USA Broad Market ETF 0.04% 88%
You may already own it

Widely held U.S. index funds. If you own one, you own MEDP through it. None of them is a Shariah fund; the last column is our look-through of each.

FundMEDP in fundFund compliant by weight
IWF iShares Russell 1000 Growth ETF 0.04% 69%
SCHB Schwab U.S. Broad Market ETF 0.02% 53%
VTI VANGUARD TOTAL STOCK MARKET INDEX FUND 0.02% 54%
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.02% 54%
Other funds
FundMEDP in fundFund compliant by weight
INSIX Catalyst Insider Buying Fund 2.45% 49%
BUL Pacer US Cash Cows Growth ETF 2.11% 70%
QMID WisdomTree U.S. MidCap Quality Growth Fund 1.20% 57%
MDYG State Street(R) SPDR(R) S & P 400(TM) Mid Cap Growth ETF 0.63% 63%
COWG Pacer US Large Cap Cash Cows Growth Leaders ETF 0.60% 76%
IVOO VANGUARD S&P MID-CAP 400 INDEX FUND 0.38% 47%
IPMSX VOYA INDEX PLUS MIDCAP PORTFOLIO 0.38% 47%
IWP iShares Russell Mid-Cap Growth ETF 0.33% 61%
JMEE JPMorgan Small & Mid Cap Enhanced Equity ETF 0.29% 42%
ESML iShares ESG Aware MSCI USA Small-Cap ETF 0.21% 40%
3 more funds
FundMEDP in fundFund compliant by weight
CVMC Calvert US Mid-Cap Core Responsible Index ETF 0.12% 42%
FSKAX Fidelity Total Market Index Fund 0.02% 51%
TIQRX Nuveen Equity Index Fund 0.02% 51%

Sorted by MEDP’s share of each fund, from the fund’s latest SEC N-PORT filing. “Compliant by weight” is the share of the fund’s holdings our look-through screens compliant. A fund is listed only where its filing is mostly equity and names MEDP once, so a bond is not counted as the shares. Shariah funds are those with a recorded certification, on our halal ETF list, or named Shariah, Islamic, Halal or Sukuk.

Tracked investors holding MEDP
InvestorFirmPositionWeightAs of
Peter Brown Renaissance Technologies $282M 0.4% 2026-09-30
Baillie Gifford Baillie Gifford & Co $282M 0.3% 2026-09-30
David Shaw D. E. Shaw & Co. $171M 0.1% 2026-09-30
Francois Rochon Giverny Capital $153M 5.2% 2026-09-30
Ken Griffin Citadel Advisors $93M 0.0% 2026-09-30
Ken Fisher Fisher Asset Management $81M 0.0% 2026-09-30
Mairs & Power Mairs & Power $54M 0.5% 2026-09-30
C.T. Fitzpatrick Vulcan Value Partners $44M 1.4% 2026-09-30
Ray Dalio Bridgewater Associates $36M 0.2% 2026-09-30
Israel Englander Millennium Management $34M 0.0% 2026-09-30
Joel Greenblatt Gotham Asset Management $24M 0.0% 2026-09-30
Jeremy Grantham GMO $21M 0.0% 2026-09-30
Terry Smith Fundsmith $16M 0.1% 2026-09-30
Steven Cohen Point72 Asset Management $10M 0.0% 2026-09-30
John Hussman Hussman Strategic Advisors $3M 0.6% 2026-09-30
Caxton Associates Caxton Associates LLP $2M 0.0% 2026-09-30
Azzad Asset Management Azzad Asset Management $1M 0.0% 2026-09-30
Jefferies Jefferies Financial Group $1M 0.0% 2026-09-30
Paul Tudor Jones Tudor Investment Corp $1M 0.0% 2026-09-30

From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.

692.68617.86543.05468.24393.422025-11-202026-05-222026-11-19

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
623.56
S2
633.47
S1
640.17
PIVOT
650.08
R1
656.78
R2
666.69
R3
673.39

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
580.24 – 657.52
±6.24% from 618.88, made 2026-09-26 · resolves 2026-10-03
STRONG BUY
from 19 indicators
78.6% of our last 30385 forecasts — across every instrument we forecast, not just this one — landed inside their stated range, and 53.9% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

SELL
19 indicators
OscillatorsNEUTRAL
3 buy · 1 neutral · 3 sell
Moving averagesSTRONG SELL
4 buy · 0 neutral · 8 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)44.80NEUTRAL
Stochastic %K (14)5.99BUY
CCI (20)-132.20BUY
Williams %R (14)-94.01BUY
MACD (12,26,9)-4.27SELL
ROC (10)-0.16SELL
Momentum (10)-1.00SELL
EMA (10)650.53SELL
SMA (10)654.83SELL
EMA (20)650.37SELL
SMA (20)659.68SELL
EMA (30)645.91SELL
SMA (30)648.60SELL
EMA (50)634.04SELL
SMA (50)634.13SELL
EMA (100)605.13BUY
SMA (100)605.78BUY
EMA (200)566.77BUY
SMA (200)533.42BUY

About MEDP

Healthcare · Diagnostics & Research

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

medpace.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Latest Signal — 2026-07-23

CANDLE
Type · SCALP
602.52
Entry
594.37
Stop
618.82
Target
WIN
Outcome · exit 618.82 (+2.71%)

Stop 594.37 Now 633.98 Target 618.82

Verdict

🟠 NOT YET

The main driver: insider selling on the open market. More negatives than positives right now. The setup isn't ready — check back when the trend or RSI changes.

Scores: 1 bullish / 2 bearish

Grade verdict

No real edge — avoid

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily RANGING 63
⏰ 4H BEARISH 38
🕐 1H BEARISH 98
⏱ 15-Min BEARISH 130
⏲ 5-Min BEARISH 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

-0.2%
Rate of change (10d)
2.7×
Volume vs its 20-day average
3.32
MACD (no fresh cross)

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is this a fatwa?

No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.

Why can the standards disagree?

Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.

How often is this re-screened?

Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.

Do I need to purify dividends?

If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

CLUSTER SELL   0 buys · 19 sells

Recent: Troendle August J. sold 545217 sh @ $620.23 (2026-08-24); Troendle August J. sold 544544 sh @ $620.38 (2026-08-25); Troendle August J. sold 540544 sh @ $620.03 (2026-08-26)

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-11-10 · Asset managers net 914130 (-14454)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.